Takara Bio Inc. announced that it has reached a distribution agreement with Nippi Inc. to distribute recombinant Laminin 511-E8 fragments (iMatrix-511), which will become available for sale in Japan on July 16th, 2013. The product will be also supplied outside Japan through Takara Bio's sales network.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,790 JPY | -0.86% | +0.70% | -2.85% |
1st Jan change | Capi. | |
---|---|---|
-2.85% | 108M | |
+4.94% | 7.88B | |
+2.93% | 6.09B | |
-5.18% | 3.76B | |
-11.51% | 3.54B | |
-12.06% | 1.21B | |
-28.83% | 1.09B | |
+15.98% | 1B | |
-8.82% | 931M | |
-14.37% | 823M |
- Stock Market
- Equities
- 7932 Stock
- News Nippi,Incorporated
- Takara Bio Inc. Reaches Distribution Agreement with Nippi Inc